posted on 2021-02-19, 19:14authored byHana Susak, Laura Serra-Saurina, German Demidov, Raquel Rabionet, Laura Domènech, Mattia Bosio, Francesc Muyas, Xavier Estivill, Geòrgia Escaramís, Stephan Ossowski
Provides additional details about a) the cohort simulation method, b) the integration of third-party rare variant association methods in rvGWAS, c) quality control analysis with rvGWAS, and d) evaluation of potential false positive rare variant calls detected within the chronic lymphocytic leukemia risk genes analysis.